申请人:Schering Aktiengesellschaft
公开号:US20040162433A1
公开(公告)日:2004-08-19
This invention is directed to lipoxin A
4
analogs of the following formula (I) and (II):
1
wherein R
1
, R
2
, R
3
, R
4
and R
5
are described herein. These analogs are useful in treating inflammatory and autoimmune disorders in humans. These analogs are also useful in treating pulmonary or respiratory tract inflammation in humans.
本发明涉及以下公式(I)和(II)的脂氧素A4类似物:1其中R1,R2,R3,R4和R5如本文所述。这些类似物在治疗人类的炎症和自身免疫性疾病方面非常有用。这些类似物还在治疗人类的肺部或呼吸道炎症方面非常有用。